Mizuho Securities Upgrades Myriad Genetics (MYGN) to Buy
Get Alerts MYGN Hot Sheet
Price: $18.92 --0%
Rating Summary:
8 Buy, 15 Hold, 5 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 10 | Down: 4 | New: 16
Rating Summary:
8 Buy, 15 Hold, 5 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 10 | Down: 4 | New: 16
Join SI Premium – FREE
Mizuho Securities upgraded Myriad Genetics (NASDAQ: MYGN) from Neutral to Buy with a price target of $50.00 (from $40.00).
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $40.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Upgrades e.l.f. Beauty (ELF) to Buy, Analyst Says Company Could Double Revenues
- Wells Fargo Upgrades Omnicom Group (OMC) to Overweight
- Wise plc (WISE:LN) (WPLCF) PT Raised to GBP7.50 at Citi
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!